Objective
Acute myocardial infarction is the deadliest end of coronary artery disease. Significant improvements have been achieved in last two decades. Primary percutaneous İntervention is accepted as a standard cure option for acute myocardial infarction. Thyroid hormones, which are known to have an effect on heart and circulation system, have a relationship with coronary artery disease and have been evaluated in various studies. On the contrary, the effect of thyroid dysfunction on primary percutaneous İntervention is not well known. In this study, the effect of thyroid hormones on clinical status of patients who are admitted successively to our Clinic with ST-segment elevation myocardial infarction (STEMI) undergoing PCI was evaluated.
Methods
203 patients with acute STEMI ( K/E: 39/164) were evaluated. Patients were grouped according to Thyroid hormone levels (T3 – T4 – TSH) as low, normal and high. Lipid parameters, GFR values and mortality in clinic, corrected TIMI frame count and EF values were compared in between the groups. Groups were homogenous by age, gender, lipid parameters and GFR values.
Methods
203 patients with acute STEMI ( K/E: 39/164) were evaluated. Patients were grouped according to Thyroid hormone levels (T3 – T4 – TSH) as low, normal and high. Lipid parameters, GFR values and mortality in clinic, corrected TIMI frame count and EF values were compared in between the groups. Groups were homogenous by age, gender, lipid parameters and GFR values.
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
